Gelteq Limited (NASDAQ:GELS – Get Free Report) shares fell 9.8% during trading on Monday . The company traded as low as $1.45 and last traded at $1.48. 19,094 shares changed hands during trading, a decline of 92% from the average session volume of 245,810 shares. The stock had previously closed at $1.64.
Gelteq Trading Down 9.8 %
The business’s 50-day moving average is $2.24.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Gelteq stock. Citadel Advisors LLC acquired a new stake in shares of Gelteq Limited (NASDAQ:GELS – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 23,748 shares of the company’s stock, valued at approximately $55,000. Citadel Advisors LLC owned approximately 0.25% of Gelteq as of its most recent filing with the Securities & Exchange Commission.
Gelteq Company Profile
Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition.
Recommended Stories
- Five stocks we like better than Gelteq
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Overbought Stocks Explained: Should You Trade Them?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Expert Stock Trading Psychology Tips
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Gelteq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelteq and related companies with MarketBeat.com's FREE daily email newsletter.
